Document Detail


Alternative strategies for the management of respiratory failure in the newborn--clinical realities.
MedLine Citation:
PMID:  12464505     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Following the introduction of surfactant in the early 1990s and the growing use of antenatal steroids since that time, the number of infants, term and preterm, suffering severe acute respiratory failure has declined. However, such babies do still occur and their management causes much debate and concern not least because of the recognised high risk of adverse outcome in these babies. This article reviews the therapeutic options available when other more routine strategies fail.
Authors:
David Field
Related Documents :
9713015 - Deficiency of laryngeal collagen type ii in an infant with respiratory problems.
639525 - Effect of tolazoline on persistent hypoxemia in neonatal respiratory distress.
8989475 - The relationship between physician behaviors and blood gas values in the first hours of...
9034275 - A randomized, controlled study of prophylactic ranitidine in preventing stress-induced ...
2243255 - An analysis of gestational age, neonatal size and neonatal death using nonparametric lo...
16651315 - The changing face of race: risk factors for neonatal hyperbilirubinemia.
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Seminars in neonatology : SN     Volume:  7     ISSN:  1084-2756     ISO Abbreviation:  Semin Neonatol     Publication Date:  2002 Oct 
Date Detail:
Created Date:  2002-12-04     Completed Date:  2003-03-20     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  9606001     Medline TA:  Semin Neonatol     Country:  England    
Other Details:
Languages:  eng     Pagination:  429-36     Citation Subset:  IM    
Affiliation:
Department of Child Health, Robert Kilpatrick Clinical Sciences Building, University of Leicester, Leicester LE2 7LX, UK. david.field@uhl-tr.nhs.uk
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Acute Disease
Bronchodilator Agents / therapeutic use*
Clinical Competence
Combined Modality Therapy
Extracorporeal Membrane Oxygenation / methods*
High-Frequency Ventilation / methods*
Humans
Infant, Newborn
Intensive Care, Neonatal
Liquid Ventilation / methods*
Nitric Oxide / therapeutic use*
Quality Assurance, Health Care
Randomized Controlled Trials as Topic
Respiratory Distress Syndrome, Newborn / therapy*
United States
Chemical
Reg. No./Substance:
0/Bronchodilator Agents; 10102-43-9/Nitric Oxide

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Weaning newborns from mechanical ventilation.
Next Document:  Surgical versus medical treatment for severe epilepsy: consequences for intellectual functioning in ...